Prior studies have confirmed that U266 and primary myeloma cells express B cell membrane markers, including high levels of CD86 and CD54 and detectable levels of HLA-DR, CD40 and CD80, which can be upregulated by IFN-γ combined with microbial Ags or by BCGV alone [17, 25]. This evidence concerns the gene CD80 and plasma cell myeloma.